GoodRx Holdings (GDRX) Gross Profit (2019 - 2026)

GoodRx Holdings has disclosed Gross Profit across 8 years of filings, most recently posting $179.4 million for Q2 2026.

• In Q2 2026, Gross Profit fell 5.43% year-over-year to $179.4 million; the TTM figure through Jun 2026 stood at $713.2 million (down 4.82% YoY), while the FY2025 annual figure was $739.3 million, down 0.65% from the prior year.
• Gross Profit came in at $179.4 million for Q2 2026 at GoodRx Holdings, up from $173.8 million in the prior quarter.
• In the past five years, Gross Profit ranged from a high of $191.0 million in Q1 2022 to a low of $161.2 million in Q3 2023.
• Average Gross Profit over 5 years is $179.0 million, with a median of $180.4 million recorded in 2023.
• The largest YoY upside for Gross Profit was 27.36% in 2022 against a maximum downside of 16.34% in 2022.
• Over 5 years, Gross Profit stood at $166.7 million in 2022, then increased by 8.83% to $181.5 million in 2023, then rose by 2.71% to $186.4 million in 2024, then retreated by 4.87% to $177.3 million in 2025, then rose by 1.18% to $179.4 million in 2026.
• Per Business Quant data, the three most recent Gross Profit figures were $179.4 million in Q2 2026, $173.8 million in Q1 2026, and $177.3 million in Q4 2025.